User profiles for Outi Vaarala
Outi VaaralaRIA IMED AstraZeneca Verified email at astrazeneca.com Cited by 23195 |
[HTML][HTML] AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland
Background Narcolepsy is a chronic sleep disorder with strong genetic predisposition causing
excessive daytime sleepiness and cataplexy. A sudden increase in childhood narcolepsy …
excessive daytime sleepiness and cataplexy. A sudden increase in childhood narcolepsy …
[PDF][PDF] The dynamics of the human infant gut microbiome in development and in progression toward type 1 diabetes
Colonization of the fetal and infant gut microbiome results in dynamic changes in diversity,
which can impact disease susceptibility. To examine the relationship between human gut …
which can impact disease susceptibility. To examine the relationship between human gut …
Environmental triggers and determinants of type 1 diabetes
Type 1 diabetes is perceived as a chronic immune-mediated disease with a subclinical
prodromal period characterized by selective loss of insulin-producing β-cells in the pancreatic …
prodromal period characterized by selective loss of insulin-producing β-cells in the pancreatic …
The “perfect storm” for type 1 diabetes: the complex interplay between intestinal microbiota, gut permeability, and mucosal immunity
It is often stated that type 1 diabetes results from a complex interplay between varying degrees
of genetic susceptibility and environmental factors. While agreeing with this principal, our …
of genetic susceptibility and environmental factors. While agreeing with this principal, our …
Fecal microbiota composition differs between children with β-cell autoimmunity and those without
…, S Hakala, GW Welling, HJ Harmsen, O Vaarala - Diabetes, 2013 - Am Diabetes Assoc
The role of the intestinal microbiota as a regulator of autoimmune diabetes in animal models
is well-established, but data on human type 1 diabetes are tentative and based on studies …
is well-established, but data on human type 1 diabetes are tentative and based on studies …
Environmental factors in the etiology of type 1 diabetes
HK Åkerblom, O Vaarala, H Hyöty… - American journal of …, 2002 - Wiley Online Library
… Outi Vaarala Outi Vaarala is professor of pediatric immunology at Linköping University,
Linköping, Sweden, and works also at the National Public Health Institute, Helsinki, Finland. Her …
Linköping, Sweden, and works also at the National Public Health Institute, Helsinki, Finland. Her …
[HTML][HTML] GAD treatment and insulin secretion in recent-onset type 1 diabetes
…, M Chéramy, M Pihl, O Vaarala… - … England Journal of …, 2008 - Mass Medical Soc
Background The 65-kD isoform of glutamic acid decarboxylase (GAD) is a major
autoantigen in patients with type 1 diabetes mellitus. This trial assessed the ability of alum-formulated …
autoantigen in patients with type 1 diabetes mellitus. This trial assessed the ability of alum-formulated …
Lactobacillus GG effect in increasing IFN-γ production in infants with cow's milk allergy
BACKGROUND: Probiotic bacteria are potentially beneficial to maturation of the infant's immune
system. OBJECTIVE: To examine the role of probiotic bacteria in treatment of cow's milk …
system. OBJECTIVE: To examine the role of probiotic bacteria in treatment of cow's milk …
Crossreaction between antibodies to oxidised low-density lipoprotein and to cardiolipin in systemic lupus erythematosus
O Vaarala, K Aho, T Palosuo, G Alfthan, M Jauhiainen… - The Lancet, 1993 - Elsevier
Serum lipoproteins contain phospholipids and modified low-density lipoprotein (LDL) may
thus act as a target for antiphospholipid antibodies. Raised concentrations of IgG antibodies …
thus act as a target for antiphospholipid antibodies. Raised concentrations of IgG antibodies …
Anti-cardiolipin antibodies and risk of myocardial infarction in a prospective cohort of middle-aged men
O Vaarala, M Mänttäri, V Manninen, L Tenkanen… - Circulation, 1995 - Am Heart Assoc
Background Data concerning the relation between anti-phospholipid (aPL) antibodies and
myocardial infarction in subjects without evidence of overt autoimmune disease are conflicting…
myocardial infarction in subjects without evidence of overt autoimmune disease are conflicting…